|
|
Office Locations:
|
2825 E. Cottonwood Parkway, Suite 330
Salt Lake City, UT 84121
Phone: 801-702-8580
Fax: 801-702-8585
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Crocker Ventures is an independent, privately held life science and healthcare investment firm that funds promising seed- and early-stage life science companies in four primary areas: biotechnology & pharmaceuticals, medical devices, drug delivery and diagnostics. The firm invests its own capital and was founded by Gary Crocker. Crocker is also the current Chairman of the Board for Merrimack Pharmaceuticals, the former Chairman of the Board for ARUP Laboratories in Research Park, and past President and CEO of Research Medical, Inc., which he founded in 1983. Forbes magazine recognized his firm for six consecutive years as one of 'America's Best 200 Small Companies.' He was one of the original investors in Theratech, Inc., and served as Vice President for Business Development for Sorenson Research.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
